Header Logo

Connection

JOSEPH JANKOVIC to Neurologic Examination

Back to Details
This is a "connection" page, showing publications JOSEPH JANKOVIC has written about Neurologic Examination.
JOSEPH JANKOVIC
Connection Strength
1.971
Neurologic Examination
  1. Parkinson's disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry. 2008 Apr; 79(4):368-76.
    View in: PubMed
    Score: 0.273
  2. Psychogenic (Functional) Movement Disorders. Continuum (Minneap Minn). 2019 Aug; 25(4):1121-1140.
    View in: PubMed
    Score: 0.150
  3. Clinimetric testing of the comprehensive cervical dystonia rating scale. Mov Disord. 2016 Apr; 31(4):563-9.
    View in: PubMed
    Score: 0.118
  4. The alien hand and related signs. J Neurol Neurosurg Psychiatry. 1992 Sep; 55(9):806-10.
    View in: PubMed
    Score: 0.093
  5. Amplitude fluctuations in essential tremor. Parkinsonism Relat Disord. 2012 Aug; 18(7):859-63.
    View in: PubMed
    Score: 0.091
  6. Progressive supranuclear palsy: motor, neurobehavioral, and neuro-ophthalmic findings. Adv Neurol. 1990; 53:293-304.
    View in: PubMed
    Score: 0.077
  7. Impact of STN-DBS on life and health satisfaction in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry. 2010 Mar; 81(3):315-9.
    View in: PubMed
    Score: 0.075
  8. Applause sign in Parkinsonian disorders and Huntington's disease. Mov Disord. 2008 Dec 15; 23(16):2307-11.
    View in: PubMed
    Score: 0.072
  9. Joint and skeletal deformities in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. Mov Disord. 2006 Nov; 21(11):1856-63.
    View in: PubMed
    Score: 0.062
  10. Long-term evaluation of deep brain stimulation of the thalamus. J Neurosurg. 2006 Apr; 104(4):506-12.
    View in: PubMed
    Score: 0.059
  11. An open-label pilot study of levetiracetam for essential tremor. Clin Neuropharmacol. 2004 Nov-Dec; 27(6):274-7.
    View in: PubMed
    Score: 0.054
  12. Clinical heterogeneity of neurodegeneration with brain iron accumulation (Hallervorden-Spatz syndrome) and pantothenate kinase-associated neurodegeneration. Mov Disord. 2004 Jan; 19(1):36-42.
    View in: PubMed
    Score: 0.051
  13. Essential tremor: a heterogenous disorder. Mov Disord. 2002 Jul; 17(4):638-44.
    View in: PubMed
    Score: 0.046
  14. Secondary paroxysmal dyskinesias. Mov Disord. 2002 Jul; 17(4):726-34.
    View in: PubMed
    Score: 0.046
  15. Tourettism and dystonia after subcortical stroke. Mov Disord. 2002 Jul; 17(4):821-5.
    View in: PubMed
    Score: 0.046
  16. The Conundrum of Dystonia in Essential Tremor Patients: How does One Classify these Cases? Tremor Other Hyperkinet Mov (N Y). 2022; 12:15.
    View in: PubMed
    Score: 0.045
  17. Functional decline in Parkinson disease. Arch Neurol. 2001 Oct; 58(10):1611-5.
    View in: PubMed
    Score: 0.043
  18. Effects of pallidotomy on gait and balance. Adv Neurol. 2001; 87:271-81.
    View in: PubMed
    Score: 0.041
  19. Gabapentin for essential tremor: a multiple-dose, double-blind, placebo-controlled trial. Mov Disord. 2000 Jul; 15(4):678-82.
    View in: PubMed
    Score: 0.040
  20. Movement and reaction times and fine coordination tasks following pallidotomy. Mov Disord. 1999 Jan; 14(1):57-62.
    View in: PubMed
    Score: 0.036
  21. Improvement of parkinsonian signs after vascular lesions of the basal ganglia circuitry. Mov Disord. 1997 Jan; 12(1):124-6.
    View in: PubMed
    Score: 0.031
  22. Cervical dystonia as the initial presentation of Huntington's disease. Mov Disord. 1996 Jul; 11(4):457-9.
    View in: PubMed
    Score: 0.030
  23. A randomized, double-blind, placebo-controlled study to evaluate botulinum toxin type A in essential hand tremor. Mov Disord. 1996 May; 11(3):250-6.
    View in: PubMed
    Score: 0.030
  24. Outcome after stereotactic thalamotomy for parkinsonian, essential, and other types of tremor. Neurosurgery. 1995 Oct; 37(4):680-6; discussion 686-7.
    View in: PubMed
    Score: 0.029
  25. Diffusion imaging of nigral alterations in early Parkinson's disease with dopaminergic deficits. Mov Disord. 2015 Dec; 30(14):1885-92.
    View in: PubMed
    Score: 0.028
  26. Botulinum toxin in movement disorders. Curr Opin Neurol. 1994 Aug; 7(4):358-66.
    View in: PubMed
    Score: 0.026
  27. What is it? Case 1, 1993: parkinsonism, dysautonomia, and ophthalmoparesis. Mov Disord. 1993 Oct; 8(4):525-32.
    View in: PubMed
    Score: 0.025
  28. Bilateral pallidal deep brain stimulation for X-linked dystonia-parkinsonism. World Neurosurg. 2014 Jul-Aug; 82(1-2):241.e1-4.
    View in: PubMed
    Score: 0.025
  29. Cocaine-related movement disorders. Mov Disord. 1993 Apr; 8(2):175-8.
    View in: PubMed
    Score: 0.024
  30. How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: comparison with the unified Parkinson's disease rating scale. Mov Disord. 2013 May; 28(5):668-70.
    View in: PubMed
    Score: 0.024
  31. Chorea and ballism. Curr Opin Neurol Neurosurg. 1992 Jun; 5(3):308-13.
    View in: PubMed
    Score: 0.023
  32. Tardive tremor. Mov Disord. 1992; 7(1):53-7.
    View in: PubMed
    Score: 0.022
  33. Persistent dystonia possibly induced by flecainide. Mov Disord. 1992; 7(1):62-3.
    View in: PubMed
    Score: 0.022
  34. Stiff-person syndrome: an autoimmune disease. Mov Disord. 1991; 6(1):12-20.
    View in: PubMed
    Score: 0.021
  35. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008 Nov 15; 23(15):2129-70.
    View in: PubMed
    Score: 0.018
  36. Depressed mood and memory impairment before and after unilateral posteroventral pallidotomy in Parkinson's disease. J Neuropsychiatry Clin Neurosci. 2008; 20(3):357-63.
    View in: PubMed
    Score: 0.017
  37. Clinical gait and balance scale (GABS): validation and utilization. J Neurol Sci. 2004 Jan 15; 217(1):89-99.
    View in: PubMed
    Score: 0.013
  38. Intrafamilial phenotypic variability of the DYT1 dystonia: from asymptomatic TOR1A gene carrier status to dystonic storm. Mov Disord. 2002 Mar; 17(2):339-45.
    View in: PubMed
    Score: 0.011
  39. Comparison of thalamotomy and pallidotomy for the treatment of dystonia. Neurosurgery. 2001 Apr; 48(4):818-24; discussion 824-6.
    View in: PubMed
    Score: 0.010
  40. Bruxism in Huntington's disease. Mov Disord. 2000 Jan; 15(1):171-3.
    View in: PubMed
    Score: 0.010
  41. Pallidotomy for generalized dystonia. Mov Disord. 1998 Jul; 13(4):693-8.
    View in: PubMed
    Score: 0.009
  42. Neurologic presentation of Wilson disease without Kayser-Fleischer rings. Neurology. 1996 Apr; 46(4):1040-3.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.